140 related articles for article (PubMed ID: 29019573)
1. Use of transfer factor in immunosuppressed surgical patients.
Garritano CRO; Nubila FD; Couto RM; Fiorelli RKA; Aun LB
Rev Col Bras Cir; 2017; 44(5):452-456. PubMed ID: 29019573
[TBL] [Abstract][Full Text] [Related]
2. Transfer factor: Potential for therapy of malignant diseases.
Neidhart JA; LoBuglio AF
Arch Otolaryngol; 1975 Nov; 101(11):664-6. PubMed ID: 1200907
[TBL] [Abstract][Full Text] [Related]
3. [Cell immunity responses in patients with widespread neoplasias following administration of transfer factor (author's transl)].
Simó-Camps E; Vich JM; García Calderón PA; Bofill D; Grau A; Anguiz A; Forcadell I
Med Clin (Barc); 1980 May; 74(10):403-7. PubMed ID: 6968012
[No Abstract] [Full Text] [Related]
4. Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses.
Goldfarb Y; Sorski L; Benish M; Levi B; Melamed R; Ben-Eliyahu S
Ann Surg; 2011 Apr; 253(4):798-810. PubMed ID: 21475023
[TBL] [Abstract][Full Text] [Related]
5. Comparison of allogeneic tumor vaccine with leukocyte transfer and transfer factor treatment of human cancer.
Jewell WR; Thomas JH; Morse P; Humphrey LJ
Ann N Y Acad Sci; 1976; 277(00):516-21. PubMed ID: 1069560
[No Abstract] [Full Text] [Related]
6. Effects of transfer factor in patients with advanced cancer.
Krown SE; Pinsky CM; Hirshaut Y; Hansen JA; Oettgen HF
Isr J Med Sci; 1978 Oct; 14(10):1026-38. PubMed ID: 310813
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of extrinsic bronchial asthma with transfer factor].
Valdés Sánchez AF; Martín Rodríguez OL; Lastra Alfonso G
Rev Alerg Mex; 1993; 40(5):124-31. PubMed ID: 9312340
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled trial of transfer factor in Stage II malignant melanoma.
Bukowski RM; Deodhar S; Hewlett JS; Greenstreet R
Cancer; 1983 Jan; 51(2):269-72. PubMed ID: 6336977
[TBL] [Abstract][Full Text] [Related]
9. [Enhancing decreased natural lymphocytotoxicity in tumor patients by transfer factor therapy].
Láng I; Nékám K; Gergely P; Petrányi G
Orv Hetil; 1983 Apr; 124(14):807-10. PubMed ID: 6866493
[No Abstract] [Full Text] [Related]
10. The role of cellular immunity in neoplasia.
Glade PR; Zaldivar NM; Mayer L; Cahill LT
Pediatr Res; 1976 May; 10(5):517-22. PubMed ID: 778771
[No Abstract] [Full Text] [Related]
11. Immunological changes after cancer treatment and participation in an exercise program.
Hayes SC; Rowbottom D; Davies PS; Parker TW; Bashford J
Med Sci Sports Exerc; 2003 Jan; 35(1):2-9. PubMed ID: 12544628
[TBL] [Abstract][Full Text] [Related]
12. [Effect of Chinese herbal medicine on immuno-inhibition caused by chemotherapy and radiotherapy].
Bai J; Cai D
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1999 Feb; 19(2):124-6. PubMed ID: 11783296
[No Abstract] [Full Text] [Related]
13. Preliminary observations using HIV-specific transfer factor in AIDS.
Pizza G; Chiodo F; Colangeli V; Gritti F; Raise E; Fudenberg HH; De Vinci C; Viza D
Biotherapy; 1996; 9(1-3):41-7. PubMed ID: 8993756
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of cancer with "immune" RNA: current status.
Pilch YH; deKernion JB
Semin Oncol; 1974 Dec; 1(4):389-95. PubMed ID: 4620442
[No Abstract] [Full Text] [Related]
15. Application of transfer factor to clinical immunotherapy.
Greco RS
Surg Gynecol Obstet; 1976 May; 142(5):765-78. PubMed ID: 772850
[No Abstract] [Full Text] [Related]
16. Improvement in delayed hypersensitivity in Hodgkin's disease with transfer factor: lymphapheresis and cellular immune reactions or normal donors.
Khan A; Hill JM; MacLellan A; Loeb E; Hill NO; Thaxton S
Cancer; 1975 Jul; 36(1):86-9. PubMed ID: 1081903
[TBL] [Abstract][Full Text] [Related]
17. Transfer factor therapy in patients with cancer.
Vetto RM; Burger DR; Nolte JE; Vandenbark AA; Baker HW
Cancer; 1976 Jan; 37(1):90-7. PubMed ID: 1247971
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of transfer factor and acyclovir in the treatment of herpes zoster.
Estrada-Parra S; Nagaya A; Serrano E; Rodriguez O; Santamaria V; Ondarza R; Chavez R; Correa B; Monges A; Cabezas R; Calva C; Estrada-Garcia I
Int J Immunopharmacol; 1998 Oct; 20(10):521-35. PubMed ID: 9839657
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy with transfer factor of recurrent herpes simplex type I.
Estrada-Parra S; Chávez-Sánchez R; Ondarza-Aguilera R; Correa-Meza B; Serrano-Miranda E; Monges-Nicolau A; Calva-Pellicer C
Arch Med Res; 1995; 26 Spec No():S87-92. PubMed ID: 8845664
[TBL] [Abstract][Full Text] [Related]
20. Transfer factor: a potential agent for cancer therapy.
LoBuglio AF; Neidhart JA
Med Clin North Am; 1976 May; 60(3):585-90. PubMed ID: 775210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
